Comparison between Speciality Medicines IPO and Wildnet Technologies IPO.
Speciality Medicines IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Wildnet Technologies IPO is a SME Bookbuilding proposed to list at BSE SME.
| Speciality Medicines IPO | Wildnet Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Ekadrisht Capital Pvt.Ltd. | Shreni Shares Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Shreni Shares Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Speciality Medicines IPO is up to ₹0.00 Cr whereas the issue size of the Wildnet Technologies IPO is up to ₹0.00 Cr. The final issue price of Speciality Medicines IPO is and of Wildnet Technologies IPO is .
| Speciality Medicines IPO | Wildnet Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 23,00,000 shares | 3,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 28,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 23,00,000 shares | 31,50,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Speciality Medicines IPO opens on , while Wildnet Technologies IPO opens on . The closing date of Speciality Medicines IPO and Wildnet Technologies IPO is , and , respectively.
| Speciality Medicines IPO | Wildnet Technologies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Speciality Medicines IPO P/E ratio is , as compared to Wildnet Technologies IPO P/E ratio of .
| Speciality Medicines IPO | Wildnet Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Speciality Medicines Limited Financial Information (Restated)
| Wildnet Technologies Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 62.70 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 40.44% | 28.07% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 34.95% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.17 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.36% | 24.62% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Speciality Medicines IPO Retail Individual Investors (RII) are offered while in Wildnet Technologies IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Speciality Medicines IPO and in Wildnet Technologies IPO.
| Speciality Medicines IPO | Wildnet Technologies IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Speciality Medicines IPO subscribed in total, whereas Wildnet Technologies IPO subscribed .
| Speciality Medicines IPO | Wildnet Technologies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
